Royal London Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.8M Hold
490,227
0.09% 200
2025
Q4
$38.7M Buy
490,227
+17,541
+4% +$1.38M 0.08% 206
2025
Q3
$37.8M Sell
472,686
-8,971
-2% -$765K 0.08% 211
2025
Q2
$43.8M Sell
481,657
-53,717
-10% -$4.9M 0.1% 184
2025
Q1
$50.2M Buy
535,374
+81,554
+18% +$7.3M 0.12% 152
2024
Q4
$41.3M Buy
453,820
+8,197
+2% +$782K 0.1% 169
2024
Q3
$46.3M Buy
445,623
+14,844
+3% +$1.51M 0.11% 158
2024
Q2
$41.8M Buy
430,779
+2,623
+0.6% +$242K 0.11% 160
2024
Q1
$38.6M Sell
428,156
-6,052
-1% -$513K 0.1% 180
2023
Q4
$34.6M Sell
434,208
-1,224
-0.3% -$92K 0.1% 174
2023
Q3
$31M Buy
435,432
+45,713
+12% +$3.42M 0.1% 175
2023
Q2
$30M Buy
389,719
+83,967
+27% +$6.5M 0.1% 171
2023
Q1
$23M Sell
305,752
-4,139
-1% -$308K 0.09% 179
2022
Q4
$24.4M Sell
309,891
-155,558
-33% -$11.7M 0.11% 164
2022
Q3
$32.7M Sell
465,449
-30,939
-6% -$2.43M 0.17% 118
2022
Q2
$39.8M Sell
496,388
-6,036
-1% -$472K 0.18% 108
2022
Q1
$38.1M Buy
502,424
+6,155
+1% +$488K 0.15% 127
2021
Q4
$42.3M Sell
496,269
-18,462
-4% -$1.44M 0.16% 123
2021
Q3
$38.9M Buy
514,731
+621
+0.1% +$49.3K 0.16% 127
2021
Q2
$41.8M Sell
514,110
-15,204
-3% -$1.24M 0.17% 120
2021
Q1
$41.7M Buy
529,314
+21,193
+4% +$1.66M 0.19% 110
2020
Q4
$43.4M Buy
508,121
+10,829
+2% +$895K 0.23% 98
2020
Q3
$37.9M Sell
497,292
-46,736
-9% -$3.56M 0.23% 89
2020
Q2
$39.4M Sell
544,028
-11,645
-2% -$827K 0.28% 83
2020
Q1
$37M Buy
555,673
+18,077
+3% +$1.27M 0.3% 79
2019
Q4
$37M Buy
537,596
+3,744
+0.7% +$255K 0.26% 92
2019
Q3
$39.2M Sell
533,852
-16,022
-3% -$1.16M 0.3% 82
2019
Q2
$39.4M Buy
549,874
+6,286
+1% +$446K 0.37% 64
2019
Q1
$37.2M Buy
543,588
+45,041
+9% +$2.91M 0.29% 80
2018
Q4
$29.7M Buy
+498,547
New +$31.2M 0.26% 93
2018
Q3
Sell
-515,517
Closed -$33.4M 538
2018
Q2
$33.4M Buy
+515,517
New +$33.7M 0.34% 68
2016
Q2
$31.4M Sell
429,733
-15,100,667
-97% -$1.08B 0.51% 43
2016
Q1
$220K Buy
15,530,400
+15,154,194
+4,028% +$1.01B 0.32% 73
2015
Q4
$25.4M Buy
376,206
+1,178
+0.3% +$78.4K 0.39% 59
2015
Q3
$23.8M Buy
+375,028
New +$24.5M 0.38% 62
2014
Q4
$241K Buy
344,106
+67,266
+24% +$4.54M 0.46% 54
2014
Q3
$18.2M Buy
276,840
+5,806
+2% +$383K 0.46% 51
2014
Q2
$17.6M Sell
271,034
-974
-0.4% -$65.3K 0.4% 59
2014
Q1
$18.3M Buy
272,008
+47,193
+21% +$2.97M 0.42% 56
2013
Q4
$14.6M Buy
224,815
+1,523
+0.7% +$97.5K 0.37% 59
2013
Q3
$14.1M Buy
223,292
+2,832
+1% +$168K 0.38% 59
2013
Q2
$12.7M Buy
+220,460
New +$13.1M 0.37% 58

Other funds holding CL

Royal London Asset Management's CL Position: Q1 2026 in Review

Royal London Asset Management held its Colgate-Palmolive (CL) position steady in Q1 2026 at 490,227 shares worth $41.8M. The position accounts for 0.09% of the portfolio, ranked #200.

Royal London Asset Management first reported a position in CL in Q2 2013 and has held it in 42 quarters since. The position peaked at $50.2M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Royal London Asset Management held 490,227 shares of Colgate-Palmolive worth $41.8M as of Q1 2026.
  • Royal London Asset Management left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.09% of Royal London Asset Management's portfolio in Q1 2026, its #200 holding.
  • Royal London Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 42 quarters since.
  • Royal London Asset Management's Colgate-Palmolive position peaked at $50.2M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.